Muchitsch E M, Teschner W, Linnau Y, Pichler L
Immuno AG, Vienna, Austria.
Arch Int Pharmacodyn Ther. 1996 May-Jun;331(3):313-21.
Anesthetized guinea-pigs were intravenously injected with Evans blue. After intracutaneous injection of agonists (lys-plasminogen, histamine, platelet-activating factor, thrombin, bradykinin), the resulting wheals appeared blue in a dose-dependent manner, due to an enhanced capillary permeability, alpha 1-Acid glycoprotein, given i.v. in different doses (3.125-50 mg/kg) and at different times (30-180 min) before Evans blue administration, antagonized the effects of all agonists listed above. This was shown by a parallel shift of the agonist dose-response curves to the right. The effect was time-dependent (tmax: mainly 120 min) and dose-dependent. alpha 1-Acid glycoprotein antagonized the agonists in the following order: lys-plasminogen > histamine = platelet-activating factor > thrombin > bradykinin. As all agonist mentioned are suggested to play a major role in the shock-related increase in vascular permeability, a putatively beneficial role of alpha1-acid glycoprotein in shock is discussed.
对麻醉的豚鼠静脉注射伊文思蓝。皮内注射激动剂(赖氨酸 - 纤溶酶原、组胺、血小板活化因子、凝血酶、缓激肽)后,由于毛细血管通透性增强,产生的风团呈剂量依赖性蓝色。在给予伊文思蓝之前,以不同剂量(3.125 - 50 mg/kg)和不同时间(30 - 180分钟)静脉注射α1 - 酸性糖蛋白,可拮抗上述所有激动剂的作用。激动剂剂量 - 反应曲线平行右移表明了这一点。该作用具有时间依赖性(tmax:主要为120分钟)和剂量依赖性。α1 - 酸性糖蛋白对激动剂的拮抗作用顺序为:赖氨酸 - 纤溶酶原>组胺 = 血小板活化因子>凝血酶>缓激肽。由于上述所有激动剂都被认为在休克相关的血管通透性增加中起主要作用,因此讨论了α1 - 酸性糖蛋白在休克中可能的有益作用。